- Home
- CPD Activities
- SGLT2 Inhibitors in the Management of T2D and Related Cardiorenal Comorbidities: A review of Current Evidence
SGLT2 Inhibitors in the Management of T2D and Related Cardiorenal Comorbidities: A review of Current Evidence
| Name | World Continuing Education Alliance |
|---|
| Activity Title | SGLT2 Inhibitors in the Management of T2D and Related Cardiorenal Comorbidities: A review of Current Evidence |
|---|
| Details | SGLT2 Inhibitors in the Management of T2D and Related Cardiorenal Comorbidities: A review of Current Evidence
By
DR. NNUNDA EZRA
MB ChB MUST, FCP ECSA, MRCP(Ass)
Physician
Department of Internal medicine
Mengo hospital |
|---|
| Competence | Internal Medicine |
|---|
| Start Date | <span class="not-set">(not set)</span> |
|---|
| End Date | <span class="not-set">(not set)</span> |
|---|
| Event Time | 09:15 PM |
|---|
| Location | World Continuing Education Alliance eLearning System |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 1 |
|---|